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ABSTRACT
Background: several prognostic systems have been develo-
ped and validated in general Intensive Care Units (ICUs). No as-
sessment of these scores was performed in specialized Gastroen-
terology Intensive Care Units (GICUs).
Aim: to assess the prognostic accuracy of Acute Physiology
and Chronic Health Evaluation (APACHE) II, Simplified Acute
Physiology Score (SAPS) II and Sequential Organ Failure Assess-
ment (SOFA) scores systems to predict mortality in a GICU.
Methods: retrospective study of 300 consecutively admissions
in a GICU. Demographics, indication for admission, APACHE II,
SAPS II and SOFA scores and survival at GICU discharge were re-
corded. Discrimination was evaluated using receiver operations
characteristic (ROC) curves and area under a ROC curve (AUC).
Calibration was estimated using the Hosmer-Lemeshow good-
ness-of-fit test.
Results: overall GICU mortality was 5.3%. APACHE II,
SAPS II and SOFA mean scores of nonsurvivors (21.9, 46.2 and
9.3, respectively) were found to be significantly higher than those
of survivors (11.9, 26.7 and 2.2, respectively) (p < 0.001). Discri-
mination was excellent for all the prognostic systems, with AUC =
0.900, 0.903 and 0.965 for APACHE II, SAPS II and SOFA, res-
pectively. Similarly, APACHE II, SAPS II and SOFA scores achie-
ved good calibration, with p = 0.671, 0.928 and 0.775, respecti-
vely. Among the three scores, SOFA showed the best
performance, with overall correctness of prediction of 94.0%,
while it was 86.2% for APACHE II and 82.7% for SAPS II.
Conclusions: in GICU, APACHE II, SAPS II and SOFA sco-
res have excellent prognostic accuracy and, among the three sco-
res, SOFA has the greatest overall correctness of prediction.
Key words: Gastroenterology Intensive Care Unit, APACHE II,
SAPS II, SOFA, prognostic scores.
INTRODUCTION
Several predictive scoring systems have been deve-
loped and validated in general Intensive Care Unit
(ICU) populations to evaluate the severity of illness
and prognosis (1-6). However, to our knowledge, no re-
ports are available on validation of these prognostic
models in specialized Gastroenterology Intensive Care
Units (GICUs).
Prognostic models can also be used for comparison
and quality assessment between different ICUs and wit-
hin the same ICU over time (7,8), for audit and clinical
research (9), as well for evaluating therapeutic effective-
ness and guiding communication between clinicians and
families (10-12).
There are two main categories of general prognostic
models)first, those evaluating the severity of illness, na-
mely Acute Physiology and Chronic Health Evaluation
(APACHE) II (13) and Simplified Acute Physiology Sco-
re (SAPS) II (14); secondly, models quantifying organ
dysfunction and failure, of which the most used is the Se-
quential Organ Failure Assessment (SOFA) (6,15). Most
prognostic models evaluate survival on discharge from
ICU, using data collected within the first 24h in ICU (1-
4,16,17).
The aim of this study was to assess the prognostic
accuracy of APACHE II, SAPS II and SOFA scores
systems in predicting mortality of patients admitted to
a GICU.
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mortality rate was 5.3% (n = 16). Mean APACHE II,
SAPS II and SOFA scores were significantly higher in
nonsurvivors (Table II).
ROC curves and corresponding AUC are illustrated in
Figure 1. The results of Hosmer-Lemeshow goodness-o-
fit tests (χ2), the best Youden index and the resultant cut-
off point are show in table III. The three scores had AUC
> 0.90, i.e., they have a good discriminative ability. Addi-
tionally, the test of model fit confirmed, for all the scores,
that predicted mortality was similar to observed mortality
(good calibration).
To assess the prognostic value of the obtained cut-off
points for predicting GICU mortality, the positive predic-
tive value, negative predictive value, sensitivity, specifi-
city and overall correctness of prediction were determi-
ned (Table IV). GICU mortality rates above and below
the cut-off points and the corresponding odds ratio for
GICU mortality where detailed in table V.
DISCUSSION
Accurate prognostic indicators for patient survival in ICUs
aid clinical decision, assist communication with families of
patients and allow comparison between units (7,12,21).
The APACHE II, SAPS II and SOFA are ICU-specific
prognostic scores widely used. Several past studies
analyze the predictive abilities of these prognostic sys-
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Table I. Indication for GICU Admission
Primary GICU admission cause n (%)
Bleeding peptic ulcer 123 (41.0)
Variceal bleeding 81 (27.0)
Acute pancreatitis 21 (7.0)
Lower gastrointestinal bleeding 15 (5.0)
Hepatic encephalopathy 9 (3.0)
Acute hepatic failure 8 (2.7)
Cholangitis 6 (2.0)
Miscelaneous/other causes 37 (12.3)
GICU, Gastroenterology Intensive Care Unit.
Table II. Average Values of APACHE II, SAPS II and SOFA
Scores According to Survival
Scoring system Survivors Nonsurvivors p value
APACHE II 11.9 ± 6,3 21.9 ± 5,4 <0.001
SAPS II 26.7 ± 10,1 46.2 ± 12.6 < 0.001
SOFA 2.2 ± 2.3 9.3 ± 3.0 < 0.001
APACHE, Acute Physiology and Chronic Health Evaluation; SAPS, Simplified Acu-
te Physiology Score; SOFA, Sequential Organ Failure Assessment.
Table III. Calibration, Youden Index and Cut-off Values of
the Scoring Systems
Scoring system Calibration Youden index Cut-off point
goodness-of-fit (χ2)
APACHE II 0.671 0.78 16
SAPS II 0.928 0.78 34
SOFA 0.775 0.88 5
APACHE, Acute Physiology and Chronic Health Evaluation; SAPS, Simplified Acu-
te Physiology Score; SOFA, Sequential Organ Failure Assessment.
Table IV. Prediction of GICU Mortality
Scoring system PPV (%) NPV (%) Sensitivity (%) Specificity (%) Overall correctness
of prediction (%)
APACHE II 19.7 99.6 93.8 78.5 86.2
SAPS II 18.2 99.1 87.5 77.8 82.7
SOFA 32.0 100 100 88.0 94.0
GICU, Gastroenterology Intensive Care Unit; APACHE, Acute Physiology and Chronic Health Evaluation; SAPS, Simplified Acute Physiology Score; SOFA, Sequential Organ
Failure Assessment; PPV, Positive Predictive Value; NPV, Negative Predictive Value.
Table V. Cut-off Points)Mortality Rate and Odds Ratio for GICU Mortality
Scoring system Mortality rate (%) p value Odds ratio for GICU mortality (95% CI)
APACHE II ≥ 16 19.7 <0.001 54.84 (7.10 – 423.39)
< 16 0.4
SAPS II ≥ 34 18.2 <0.001 24.56 (5.44-110.91)
< 34 0.9
SOFA ≥ 5 32.0 <0.001 Infinite
< 5 0
GICU, Gastroenterology Intensive Care Unit; APACHE, Acute Physiology and Chronic Health Evaluation; SAPS, Simplified Acute Physiology Score; SOFA, Sequential Organ
Failure Assessment; CI, Confidence Interval.
METHODS
Patients
This is a retrospective study of 300 consecutively ad-
missions (288 patients) in a 4-bed specialized GICU at a
1200-bed university hospital in Portugal, between Fe-
bruary 2005 and October 2006. In this unit patients with
hepatic and/or gastrointestinal severe medical diseases
are admitted. Surgical patients, including post-transplant,
are not admitted in this GICU, since there are specific
units in our hospital for these patients. Hospitalizations
with GICU stay < 24 hours were excluded from the study.
For the purposes of this study, each admission was consi-
dered a separate patient.
Data collected included demographics, indication for
admission, APACHE II, SAPS II and SOFA scores and
survival at GICU discharge. The scores were computed
for each patient using data collected within the first 24h
in GICU, selecting, for each variable, the worst (most ab-
normal) value during this period.
The main study outcome was GICU mortality.
Ethical approval
Ethical approval for this research was given by the lo-
cal Ethics Committee.
Statistical Analysis
Categorical variables were expressed as frequency and
percentage, and the corresponding contingency tables
were analyzed with Pearson’s chi-square test or Fisher’s
exact test, as appropriate. Odds ratios (OR) were determi-
ned with 95% confidence intervals (95% CI).
Continuous variables were summarized using means
and standard deviation (and range). These variables were
tested for normal distributions using Kolmogorov-Smir-
nov test. Student’s t test was employed to compare the
means of continuous variables and normally distributed
data; otherwise, the Mann-Whitney U test was employed.
A p value less than 0.05 was considered statistically sig-
nificant.
The model performance is usually evaluated statisti-
cally by measuring calibration and discriminative ability
(1,18).
Calibration (i.e., the degree of correspondence betwe-
en predicted and observed mortality over the entire range
of risks) was described by the goodness-of-fit testing
using the Hosmer-Lemeshow test. As usually, a p value >
0.2 was considered good (19).
Discrimination (i.e., the model’s ability to differentiate
between patients who died and those who survived) was
examined with receiver operation characteristic (ROC)
curves, using area under the curve (AUC), which is a plot
of true positive rate (sensitivity) vs false positive rate (1-
specificity) (19). The AUC ranges from 0 to 1, with 0.5
corresponding to what is expected by chance alone and
1.0 to perfect discrimination. In general, an AUC > 0.7
indicates a useful test (20). AUC between 0.7 and 0.8
were classified as “acceptable” and > 0.8 as “excellent”
discrimination (21).
Finally, cut-off points were calculated by obtaining the
best Youden index (sensitivity + specificity -1) (22). Po-
sitive predictive value, negative predictive value, sensiti-
vity, specificity, overall correctness of prediction and
odds ratio for GICU mortality were then calculated using
the obtained cut-off values.
The data was analyzed with the Statistical Package for
Social Sciences-SPSS (SPSS Inc., Chicago, Illinois,
USA) computer software for Windows (version 17.0).
RESULTS
A total of 288 patients represented 300 cases (admis-
sions). Of the 300 cases, 199 were male (66%) and 101
were female (34%). The mean age was 63.9 ± 17.6 (range
17-97 years) and all patients were white. This sample in-
cluded 124 (41.3%) admissions of patients with history
of liver cirrhosis, mostly (80.6%, n = 100) alcoholic liver
cirrhosis.
Upper gastrointestinal bleeding (68%, n = 204) was
the most common reason for GICU admission, including
123 (41.0%) patients with bleeding peptic ulcers and 81
(27.0%) with variceal bleeding. The 123 patients admit-
ted with bleeding peptic ulcers included 74 (60.2%) duo-
denal ulcers, 46 (37.4%) gastric ulcers and 3 (2.4%) anas-
tomotic ulcers. The endoscopic stigmata of these ulcers
were as following: 7 (5.7%) – Forrest Ia; 32 (26.0%) -
Forrest Ib; 49 (39.9%) - Forrest IIa; 26 (21.1%) - Forrest
IIb; 6 (4.9%) - Forrest IIc; 3 (2.4%) - Forrest III. Of the
81 patients admitted with variceal bleeding, 69 patients
had esophageal variceal bleeding and 12 gastric variceal
bleeding. The primary treatment for esophageal variceal
bleeding was elastic band ligation, sclerosis (with absolu-
te alcohol) and Sengstaken Blackmore balloon tampona-
de in 30 (43.5%), 21 (30.4%) and 18 (26.1%) patients,
respectively. In the 12 patients admitted with gastric vari-
ceal bleeding the primary treatment was Histoacryl® + Li-
piodol in 11 (91.7%) patients and Sengstaken Blackmore
balloon tamponade in 1 (8.3%) patient. Table I lists the
reasons for GICU admission.
Acute renal failure or acute-on-chronic renal failure
was found in 62 (20.7%) patients, requiring dialysis in 11
patients (3.7%). Twenty-three patients (7.7%) required
endotracheal intubation, including 15 (5.0%) with me-
chanical ventilation.
Mean ± standard deviation (and range) of APACHE II,
SAPS II and SOFA scores were 12.4 ± 6.7 (0-44), 27.8 ±
11.2 (6-72) and 2.6 ± 2.9 (0-16), respectively. The GICU
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tems in ICU populations and sub-populations (1-4,17,23-
25). However, to our knowledge, no assessment of these
scores was developed in specialized GICU.
APACHE II, a measure of severity of disease (13), has
previously been used to risk stratify patients with upper
gastrointestinal bleeding (26,27), acute pancreatitis (28-
31) and abdominal sepsis (32). Thus, it is expected that
APACHE II and, by extrapolation, probably the other
scores, may have prognostic ability in GICU.
Our study assessed, to our knowledge for the first
time, the accuracy of prognostic scores in patients admit-
ted to a GICU. In our series, discrimination and calibra-
tion was excellent for all the scores (Fig. 1 and Table III).
This means that the scores have very good ability to clas-
sify patients correctly as survivors or nonsurvivors and
that model predicted mortality was similar to observed
mortality. The high sensitivity, specificity, overall co-
rrectness of prediction and negative predictive value con-
firm the excellent right classification rates of the tested
scoring systems in GICU (Table IV). The low positive
predictive values are an unsurprising and somewhat ine-
vitable consequence of the low mortality rate (Table IV).
Nevertheless, these relatively low positive predictive va-
lues are strong enough to justify a significantly higher
mortality in patients with score values above the cut-off
points (Table V).
Among the three scores, SOFA showed the best perfor-
mance, with overall correctness of prediction 7.8% and
11.3% greater than that of APACHE II and SAPS II sco-
res, respectively (Table IV). Although the SOFA was not
developed to predict outcome but to describe the degree
of organ dysfunction in critically ill patients, several stu-
dies showed its predictive ability in patients admitted to
ICUs (16,33-36). Additionally, the variables needed to
record the SOFA are derived from standard monitoring of
critically ill patients and calculation at the bedside takes
only 3 minutes (36). These elements are important becau-
se for any predictive model to be clinically useful, it must
show ease of use, accuracy and reproducibility (37, 38).
However, there are some limitations of the SOFA that
should be addressed. Diagnosis, age and co-morbid con-
ditions are ignored. Glasgow Coma Scale is the neurolo-
gical variable assessed, but its clinical evaluation is sub-
jective and it is affected by sedative and analgesic drugs
frequently used in critically ill patients. The liver func-
tion was evaluated with serum bilirubin although it has li-
mited ability to reflect the full spectrum of liver dysfunc-
tion in critical illness and it cannot differentiate acute
liver dysfunctions from the effects of pre-existing chronic
disease. This may be mostly important in GICU where a
significant proportion of patients have liver disease.
Established prognostic models are usually estimated
after the first 24 h of ICU admission (1-4,16,17). Thus,
current models may not be suitable to decide on the ap-
propriateness of admission to ICU, as clinical status may
improve over the first 24h with therapy or deteriorate due
to complications (39). Other limitations are that they
were not designed to predict prognosis for long stays or
after ICU discharge and do not evaluate end-points other
than mortality, such as cost-effectiveness, recovery, phy-
sical activity or quality of life (19,40-42).
The evaluated scores were calibrated to predict the
outcome in the original development samples, that were
extracted from general ICUs where the mortality rate is
significantly higher than in our unit (13,14,16). In addi-
tion, it is well known fact that mortality prediction model
performance usually deteriorates when models are ap-
plied to different population samples, i.e. less sick pa-
tients. Indeed, although APACHE II works well for seve-
rely ill cirrhotic patients admitted to ICUs (17,43-47),
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Fig. 1. Receiver operation characteristic (ROC) curves and corresponding area under the curve (AUC) for Acute Physiology and Chronic Health Evalua-
tion (APACHE) II, Simplified Acute Physiology Score (SAPS) II and Sequential Organ Failure Assessment (SOFA) in 300 consecutive admissions to a Gas-
troenterology Intensive Care Unit.
this is not the case when its predictive value is assessed in
a population of cirrhotic patients with mortality rate of
only 11.5% (48). Thus, our results are somewhat surpri-
sing, because the mortality rate in our sample was only
5.3% and nevertheless the scores showed an excellent
performance.
Potential limitations of our study should be mentioned.
Firstly, it is a retrospective study. Secondly, this work
was performed in an academic referral hospital; therefore
our results may not be applicable to institutions with dif-
ferent populations. Finally, patients with GICU stay < 24
hours were excluded, resulting in a mortality rate of only
5.3%. It could be stated that the rational of excluding the-
se patients weakens our study, because the most likely is
that these patients have died. However, this problem is
shared by all the other works in this area, as the tested
scores, by definition, must be calculated with the worst
value for each variable obtained during the first 24h of
admission.
Despite the excellent performance of the tested scores
in our study, its structure has some limitations in the
prognostic assessment of patients admitted in a GICU.
Indeed, prothrombin time and blood units transfused are
not measured by the scores, and they are presumably im-
portant prognostic variables in a population with high in-
cidence of cirrhosis and in which the principal reason for
admission was upper gastrointestinal bleeding. Therefo-
re, in the future, it would be interesting to develop studies
to identify independent risk factors in patients admitted
to a GICU and, based on them, develop a specific score
for this context.
Objective prognostic estimates can be useful as an im-
portant tool in the decision making process. However,
probability models can never predict whether a patient
will live or die with 100% accuracy (49-51). Thus, these
probabilities should be used to complement and enhance,
not as a substitute for clinical judgment.
In conclusion, our data showed that APACHEII, SAPS
II and SOFA scores have excellent discrimination and ca-
libration in GICU and, therefore, are clinically useful in
this context. Furthermore, our results indicate that among
the three scores, SOFA has the greatest overall correct-
ness of prediction. Nevertheless, a validation of our re-
sults is required in others GICU, preferably prospecti-
vely. Prognostic scoring systems cannot replace the
clinical evaluation of the patients. However, we believe
that these scores may improve the physician’s estimate of
prognosis and, hence, be useful in clinical decision ma-
king.
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